InvestorsHub Logo

frrol

10/07/20 7:51 AM

#274243 RE: Investor2014 #274239

Simonian is excellent. He's likely close to correct about the biological pathologies, and is correct about the trial impacts and share price. I correspond with him. Worth reading.

(For the who need the warning: he does not "know" the drug works.)